Trade DMAA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Drugs Made In America Acquisition Corp. (DMAA) is trading at US$10.76, up 0.09% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$260.98M. Over the past 52 weeks, DMAA has traded between US$10.23 and US$10.77. On Syfe you can trade DMAA with $0 commission and add it to your watchlist.
| Previous close | US$10.75 |
|---|---|
| Market cap | US$260.98M |
| 52-week range | US$10.23 – US$10.77 |
| Volume | 29.71K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in New York, NY.
Year: 2025
Drugs Made In America Acquisition Corp. (DMAA) stock is trading at US$10.76, +0.09% from the previous close of US$10.75.
The market cap for Drugs Made In America Acquisition Corp. (DMAA) stock is approximately US$260.98M.
The 52-week high for Drugs Made In America Acquisition Corp. (DMAA) stock is US$10.77.
The 52-week low for Drugs Made In America Acquisition Corp. (DMAA) stock is US$10.23.
Drugs Made In America Acquisition Corp. (DMAA) does not currently pay a dividend.
Stay on top of DMAA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
